LOS ANGELES, Oct. 19, 2017 -- Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Top Ships Inc. (“Top Ships” or the “Company”) (Nasdaq:TOPS) for possible violations of federal securities laws from January 17, 2017 through August 22, 2017, inclusive (the “Class Period”). Investors who purchased or otherwise acquired Top Ships shares during the Class Period should contact the firm before October 23, 2017, the lead plaintiff motion deadline.
To participate in this class action lawsuit, click here.
You can also call Brian Lundin, Esq., of Lundin Law PC, at 888-713-1033, or you can e-mail him at [email protected].
No class has been certified in the above action yet, and until a class is certified, you are not considered to be represented by an attorney. You may also choose to do nothing and be an absent class member.
The Complaint alleges that throughout the Class Period, CEO Evangelos J. Pistiolis caused the Company to engage in a series of manipulative share issuance and sales transactions with Kalani Investments Limited (“Kalani”) through which Top Ships would sell its common shares and securities convertible into common shares to Kalani at a significant discount to market price and file registration statements so that Kalani could resell these shares into the market. When Kalani’s sales of Top Ships stock caused its share price to decline, the Company would reverse split the stock, causing a certain number of outstanding shares to be merged into a single share, and thereby raise its stock price. Then, the Company would again sell securities to Kalani, and the same pattern of transactions would ensue. While Top Ships was engaging in these transactions, the Company failed to disclose the true purpose of the transactions and related stock issuances and reverses – to finance related-party transactions and acquisitions that primarily benefited Mr. Pistiolis and his related companies, and otherwise funnel money to Company insiders. By August 2017, Top Ships, through Kalani, issued and sold into the market tens of millions of shares of its common stock, vastly diluting the Company’s existing shareholders. While Top Ships used the proceeds from these offerings to further enrich Mr. Pistiolis and his affiliates through various related-party transactions, the value of the Company’s common stock has fallen by more than 99%, which caused investors harm.
Lundin Law PC was created by Brian Lundin, Esq., a securities litigator based in Los Angeles dedicated to upholding the rights of shareholders.
This press release may be considered Attorney Advertising in certain jurisdictions under the applicable law and rules of ethics.
Contact:
Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
[email protected]
http://lundinlawpc.com/


Samsung Signals Comeback With HBM4 Chips as AI Market Heats Up
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Bain Capital Moves to Acquire Majority Stake in Echo Marketing
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing 



